These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2145023)

  • 21. The clinical pharmacology of ondansetron.
    Blackwell CP; Harding SM
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S21-4; discussion S25-7. PubMed ID: 2533895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous ondansetron plus intravenous dexamethasone with different ondansetron dosing schedules during multiple cycles of cisplatin-based chemotherapy.
    Chen PT; Liaw CC
    Chang Gung Med J; 2008; 31(2):167-74. PubMed ID: 18567417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of oral granisetron versus intravenous ondansetron for antiemetic prophylaxis in patients undergoing laparoscopic surgery: the effect on emetic symptoms and quality of recovery.
    White PF; Tang J; Hamza MA; Ogunnaike B; Lo M; Wender RH; Naruse R; Sloninsky A; Kariger R; Cunneen S; Khalili T
    Anesth Analg; 2006 May; 102(5):1387-93. PubMed ID: 16632815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ondansetron: perioperative use of a serotonin receptor antagonist for the prevention and treatment of nausea and vomiting.
    Early TE; Charbonneau J; McKnight G; Jenkins P
    J Post Anesth Nurs; 1995 Dec; 10(6):320-3. PubMed ID: 8632370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical studies of oral antiemetic drugs on delayed emesis induced by cancer chemotherapy].
    Sawaguchi K; Yabushita H; Tsukada H; Yamada H; Noguchi M; Nakanishi M
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):117-23. PubMed ID: 9987507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiemetic therapy in managed care oncology: roundtable discussion.
    Gerbino PP; Goldsmith M; Kenney JT; Lindley C; Nolte J; Quan W; Reich PR
    Med Interface; 1996 Sep; Suppl C():16-35. PubMed ID: 10161507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidural ondansetron is more effective to prevent postoperative pruritus and nausea than intravenous ondansetron in elective cesarean delivery.
    Han DW; Hong SW; Kwon JY; Lee JW; Kim KJ
    Acta Obstet Gynecol Scand; 2007; 86(6):683-7. PubMed ID: 17520399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-HT3-receptor antagonists in the control of delayed-onset emesis.
    Gridelli C
    Anticancer Res; 2003; 23(3C):2773-82. PubMed ID: 12926112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceutical development of ondansetron tablets.
    Leak RE; Woodford JD
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S63-6. PubMed ID: 2533901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An outline of 5-HT3 receptor antagonists (1)--In pharmacological actions].
    Tsukagoshi S; Ohta J; Taguchi T
    Gan To Kagaku Ryoho; 1993 Nov; 20(14):2108-14. PubMed ID: 8239673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ramosetron versus ondansetron in the prevention of chemotherapy-induced gastrointestinal side effects: A prospective randomized controlled study.
    Shi Y; He X; Yang S; Ai B; Zhang C; Huang D; Dong M; Liu P; Zhou S; Han X
    Chemotherapy; 2007; 53(1):44-50. PubMed ID: 17202811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report.
    Habib AS; Gan TJ
    J Clin Anesth; 2005 Feb; 17(1):62-5. PubMed ID: 15721732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using ondansetron with pediatric patients undergoing total body irradiation.
    Witherow P; Wilson K
    Oncol Nurs Forum; 1991; 18(8):1416-7. PubMed ID: 1837082
    [No Abstract]   [Full Text] [Related]  

  • 34. Scheduled prophylactic ondansetron administration did not improve its antiemetic efficacy after intracranial tumour resection surgery in children.
    Subramaniam K; Pandia MP; Dash M; Dash HH; Bithal PK; Bhatia A; Subramaniam B
    Eur J Anaesthesiol; 2007 Jul; 24(7):615-9. PubMed ID: 17261211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlling conditioning-related emesis in children undergoing bone marrow transplantation.
    Mehta NH; Reed CM; Kuhlman C; Weinstein HJ; Parsons SK
    Oncol Nurs Forum; 1997 Oct; 24(9):1539-44. PubMed ID: 9348595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Freeze dried ondansetron: first observations with the fast dissolving oral antiemetic Zofran Zydis for the prophylaxis of the cisplatin-induced emesis in gynecological cancer patients.
    Lehoczky O; Udvary J; Pulay T
    Neoplasma; 2002; 49(2):126-8. PubMed ID: 12088106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ondansetron in carcinoid syndrome.
    Platt AJ; Heddle RM; Rake MO; Smedley H
    Lancet; 1992 Jun; 339(8806):1416. PubMed ID: 1375972
    [No Abstract]   [Full Text] [Related]  

  • 38. Stability of ondansetron hydrochloride in a total parenteral nutrient admixture.
    Kirkham JC; Rutherford ET; Cunningham GN; Daneshmand KA; Falls AL
    Am J Health Syst Pharm; 1995 Jul; 52(14):1557-8. PubMed ID: 7552902
    [No Abstract]   [Full Text] [Related]  

  • 39. Enzyme-linked immunosorbent assay for ondansetron captured from airborne samples.
    Hreczuk-Hirst D; Rowell FJ; Reeve RN; Cumming RH; Guest I
    Analyst; 1998 May; 123(5):1121-6. PubMed ID: 9709495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is ondansetron "too expensive"?
    Pannuti F; Tanneberger S; Lelli G; Piana E
    Lancet; 1992 Mar; 339(8793):614-5. PubMed ID: 1347112
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.